2012 Singapore - 2nd Annual Biomarkers in Diagnostics & Therpaeutics

Biomarker has become a buzz word in both the pharmaceuticals and diagnostics sectors within the last few years, with promising results in pharmacogenomics studies and molecular diagnostics; and especially in the field of drug-diagnostic co-development where it’s potential in companion diagnostics have been fuelling the ultimate promise of a future towards personalised healthcare.
BDT2012 congregates the insights of leaders from the diagnostics, pharmaceuticals, medical and academic fields to evaluate developments that have materialised from the promise of biomarker R&D.
We will review progresses in areas of companion diagnostics, clinical drug development and in personalising treatment options with a reality check on translating biomarker studies into clinical practice.

For additional information and registration